Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus

Hepatitis C infection is a global disease that causes an estimated 399,000 deaths per year. Treatment has improved dramatically in recent years through the development of direct acting antivirals that target specific regions of the Hepatitis C virus (HCV). Unfortunately the virus can have a preexist...

Full description

Bibliographic Details
Main Author: Vigetun Haughey, Caitlin
Format: Others
Language:English
Published: Uppsala universitet, Institutionen för biologisk grundutbildning 2019
Subjects:
HCV
RAS
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-387407
id ndltd-UPSALLA1-oai-DiVA.org-uu-387407
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-3874072019-06-25T09:10:26ZValidation of a new software for detection of resistance associated substitutions in Hepatitis C-virusengVigetun Haughey, CaitlinUppsala universitet, Institutionen för biologisk grundutbildning2019Hepatitis C virusHCVResistanceNS5AResistance associated substitutionsRASPacBio sequencingBioinformaticsHepatit C virusHCVResistensNS5ASekvenseringPacBioBioinformatikBioinformatics (Computational Biology)Bioinformatik (beräkningsbiologi)Hepatitis C infection is a global disease that causes an estimated 399,000 deaths per year. Treatment has improved dramatically in recent years through the development of direct acting antivirals that target specific regions of the Hepatitis C virus (HCV). Unfortunately the virus can have a preexisting resistance or become resistant to these drugs by mutations in the genes that code for the target proteins. These mutations are called resistance-associated substitutions (RASs). Since RASs can cause treatment failure for patients, resistance detection is performed in clinical practice to select the ideal regimen. Currently RASs are detected by using Sanger sequencing and a partly manual workflow that can discriminate the presence of a RAS if it is present in 15-20% of viruses in a patients blood. A new method with the capacity to detect lower ratios of RASs in HCV sequences was developed, which utilizes Pacific Biosciences’ (PacBio’s) sequencing and a bioinformatics analysis software called CLAMP. To validate this new approach, 123 HCV patient samples were sequenced with both methods and then analyzed. The RASs detected with the new method were congruent to what was found with the Sanger-based workflow. The new approach was also shown to correctly genotype the virus samples, identify any co-existing mutations on the same sequences, and detect if there were any mixed genotype infections in the samples. The new procedure was found to be a valid replacement for the Sanger based workflow, with the possibility to perform additional analyses and perform automated and time efficient RAS detection. Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-387407UPTEC X ; 19 015application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Others
sources NDLTD
topic Hepatitis C virus
HCV
Resistance
NS5A
Resistance associated substitutions
RAS
PacBio sequencing
Bioinformatics
Hepatit C virus
HCV
Resistens
NS5A
Sekvensering
PacBio
Bioinformatik
Bioinformatics (Computational Biology)
Bioinformatik (beräkningsbiologi)
spellingShingle Hepatitis C virus
HCV
Resistance
NS5A
Resistance associated substitutions
RAS
PacBio sequencing
Bioinformatics
Hepatit C virus
HCV
Resistens
NS5A
Sekvensering
PacBio
Bioinformatik
Bioinformatics (Computational Biology)
Bioinformatik (beräkningsbiologi)
Vigetun Haughey, Caitlin
Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus
description Hepatitis C infection is a global disease that causes an estimated 399,000 deaths per year. Treatment has improved dramatically in recent years through the development of direct acting antivirals that target specific regions of the Hepatitis C virus (HCV). Unfortunately the virus can have a preexisting resistance or become resistant to these drugs by mutations in the genes that code for the target proteins. These mutations are called resistance-associated substitutions (RASs). Since RASs can cause treatment failure for patients, resistance detection is performed in clinical practice to select the ideal regimen. Currently RASs are detected by using Sanger sequencing and a partly manual workflow that can discriminate the presence of a RAS if it is present in 15-20% of viruses in a patients blood. A new method with the capacity to detect lower ratios of RASs in HCV sequences was developed, which utilizes Pacific Biosciences’ (PacBio’s) sequencing and a bioinformatics analysis software called CLAMP. To validate this new approach, 123 HCV patient samples were sequenced with both methods and then analyzed. The RASs detected with the new method were congruent to what was found with the Sanger-based workflow. The new approach was also shown to correctly genotype the virus samples, identify any co-existing mutations on the same sequences, and detect if there were any mixed genotype infections in the samples. The new procedure was found to be a valid replacement for the Sanger based workflow, with the possibility to perform additional analyses and perform automated and time efficient RAS detection.
author Vigetun Haughey, Caitlin
author_facet Vigetun Haughey, Caitlin
author_sort Vigetun Haughey, Caitlin
title Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus
title_short Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus
title_full Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus
title_fullStr Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus
title_full_unstemmed Validation of a new software for detection of resistance associated substitutions in Hepatitis C-virus
title_sort validation of a new software for detection of resistance associated substitutions in hepatitis c-virus
publisher Uppsala universitet, Institutionen för biologisk grundutbildning
publishDate 2019
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-387407
work_keys_str_mv AT vigetunhaugheycaitlin validationofanewsoftwarefordetectionofresistanceassociatedsubstitutionsinhepatitiscvirus
_version_ 1719209277478928384